What is the official ID of this bill?
The official print number for this legislation is HR 4101.
Equal Costs for Cancer Drugs: Oral vs. Provider-Administered
This new law aims to equalize the costs of cancer medications, whether taken orally at home or administered intravenously by a healthcare provider. This means health insurance plans cannot charge more for oral medications, potentially reducing patients' out-of-pocket expenses for treatment. The changes will take effect from January 1, 2026.
Key points
Health insurance plans must cover oral cancer drugs with cost-sharing no less favorable than for provider-administered cancer drugs.
Plans are prohibited from increasing out-of-pocket costs or reclassifying benefits to circumvent these new rules.
The law does not mandate the use of oral medications over other forms of treatment and allows for prior authorization.
A study will be conducted within two years to assess the law's impact on patients' treatment costs.
Status:
Introduced
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.